Annals of Emergency Medicine
Volume 54, Issue 1 , Page 85 , July 2009

Commentary

References 

  1. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children—United States, 1998-2000. MMWR Morb Mortal Wkly Rep. 2002;51:234–237
  2. Centers for Disease Control and Prevention. Invasive Haemophilus influenzae type b disease in five young children—Minnesota, 2008. MMWR Morb Mortal Wkly Rep. 2009;58:58–60
  3. Schuchat A, Robinson K, Wenger J, et al. Bacterial meningitis in the United States in 1995. N Engl J Med. 1997;337:970–976
  4. Pelota H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302–317
  5. World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec. 2006;81:445–452
  6. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med. 2000;36:602–614
  7. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guidelines for the management of infants and children with fever without source 0-36 months of page. Pediatrics. 1993;92:1–12

 Section editors: David A. Talan, MD; Gregory J. Moran, MD; Robert Pinner, MD

PII: S0196-0644(09)00530-7

doi: 10.1016/j.annemergmed.2009.05.020

Annals of Emergency Medicine
Volume 54, Issue 1 , Page 85 , July 2009

Article Tools